the e3 ligase trim15 promotes nsclc progression via the keap1–nrf2 signaling pathway
Published 2 years ago • 61 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:43
loss of function mutations in keap1 drive lung cancer progression
-
1:48
titan 3t & titan 1.5t mr systems
-
34:35
phase i clinical trials 3.0
-
8:16
case based panel discussion - stage 3 nsclc best schedule - durvalumab/imfinzi in varying patients
-
4:04
unmet needs in nsclc that egfr inhibitor bdtx-1535 aims to address
-
4:03
ut southwestern kidney cancer program annual event 2015
-
1:04:59
march 17, 2021
-
16:50
prof. e. de kerviler at cirse 2017 - "interventional oncology beyond liver interventions"
-
1:00
prof. ronit sacthi-fainaro - cancer research, p-selectin blockers and 3d printing
-
20:10
lira clinical webinar - save the shoelace! telomere and anti-aging technology 01/25/21
-
1:01
model cs15 rsc case closer
-
11:22
ers vision - a new prognosis for lung cancer: major advances in diagnostics and therapeutics
-
1:03
model cs15 case closer for rsc cases
-
7:33
debate: should you use third-line (salvage) therapy to manage patients with advanced nsclc? - no
-
4:57
treating egfr nsclc brain metastases
-
13:24
concurrent chemoradiation therapy (ccrt): the standard of care in unresectable stage iii nsclc
-
4:16
rescuer: resistance under combinatorial treatment in er and er- breast cancer